MAT recovery, short for Medication-Assisted Treatment, is a way of treating opioid or alcohol addiction that combines FDA-approved medications with counseling and behavioral therapy. Rather than relying on willpower or therapy alone, MAT uses specific drugs that act on the brain’s receptors to reduce cravings and withdrawal symptoms, making it easier to stay in recovery long-term. People receiving MAT for opioid use disorder have an 80 percent lower risk of dying from an overdose compared to those in treatment without medication.
How MAT Works
Addiction changes brain chemistry. Opioids, for example, flood the brain’s reward system, and over time the brain adapts so that it needs the substance just to feel normal. MAT medications target those same pathways but in a controlled, stable way that doesn’t produce the high of illicit use. This is paired with counseling or behavioral therapy to address the psychological and social sides of addiction.
Treatment typically begins with stabilization and managing withdrawal symptoms, then shifts into a maintenance phase where medication continues alongside regular therapy sessions. Patients in opioid treatment programs are required to receive counseling as part of their care. The combination is what defines MAT: medication alone isn’t MAT, and therapy alone isn’t MAT. It’s the pairing of both.
Medications for Opioid Use Disorder
Three medications are FDA-approved for treating opioid use disorder: buprenorphine, methadone, and naltrexone. Each works differently.
- Buprenorphine partially activates the same brain receptors that opioids target, but at a much lower level. It reduces cravings and withdrawal without producing a significant high. Buprenorphine is often combined with naloxone (sold as Suboxone) and is the most practical option for outpatient settings like a family medicine office, meaning you don’t necessarily need to visit a specialized clinic.
- Methadone fully activates those same receptors in a slow, controlled way. It’s been used for decades and is typically dispensed at specialized clinics where patients visit daily or near-daily, at least initially.
- Naltrexone takes the opposite approach. Instead of activating opioid receptors, it blocks them entirely. If you take an opioid while on naltrexone, you won’t feel its effects. For opioid use disorder specifically, the injectable form is used rather than the oral pill.
Medications for Alcohol Use Disorder
MAT isn’t only for opioid addiction. Three FDA-approved medications also exist for alcohol use disorder: naltrexone, acamprosate, and disulfiram.
Naltrexone works similarly for alcohol as it does for opioids, blocking the rewarding effects of drinking so alcohol becomes less appealing. Acamprosate helps restore the brain’s chemical balance after someone has stopped drinking, reducing the ongoing discomfort that can drive relapse. Disulfiram takes a different route: it causes unpleasant physical reactions (nausea, flushing, headache) if you drink alcohol while taking it, creating a strong deterrent.
One important distinction: none of these three medications treat the acute symptoms of alcohol withdrawal, which can be severe and even life-threatening. Withdrawal management is a separate medical process that may require hospitalization before MAT begins.
The Counseling Side of MAT
The medication component gets most of the attention, but counseling is equally central to MAT. Behavioral therapies help you identify triggers, build coping strategies, repair relationships, and address underlying mental health conditions like depression or anxiety that often accompany addiction.
The specific type of therapy varies. Cognitive behavioral therapy, contingency management, motivational interviewing, and group counseling are all common. What matters is that some structured form of psychosocial support runs alongside the medication. The medication stabilizes brain chemistry enough for the person to engage meaningfully in therapy, and the therapy builds the skills needed for sustained recovery.
Who Is a Candidate for MAT
Clinicians use a standardized assessment framework developed by the American Society of Addiction Medicine to determine whether someone is a good fit for MAT and what level of care they need. The evaluation covers six areas: withdrawal risk, other medical conditions, mental health status, readiness to change, relapse potential, and the person’s living environment and support system. The goal is to match each patient to the least intensive level of care that’s still safe and effective for their situation.
This means MAT looks different for different people. Someone with a stable home, a job, and mild-to-moderate opioid dependence might receive buprenorphine prescriptions from their family doctor and attend weekly therapy. Someone with severe addiction, co-occurring mental illness, and an unstable living situation might start in a more intensive program with daily clinic visits.
Why MAT Is Not “Trading One Addiction for Another”
This is the most common criticism people encounter, and it misunderstands how these medications work. Illicit opioid use floods the brain with a rapid, intense surge that creates euphoria and drives compulsive behavior. MAT medications like buprenorphine and methadone activate the same receptors, but slowly and at controlled doses that stabilize brain function without producing that surge. The person feels normal, not high.
The outcomes support this distinction clearly. A study examining over 48,000 patients with opioid use disorder found that those treated with medications like methadone or buprenorphine had an 80 percent lower risk of fatal overdose compared to patients in treatment without medication. Being in any form of treatment was protective compared to no treatment at all, but medication made the largest difference. MAT keeps people alive and in treatment long enough for recovery to take hold.